Home›Companies›Biotech & Pharma›Axonis Therapeutics

Axonis Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing Nov 1, 2024·Suggest an edit

About Axonis Therapeutics

Axonis Therapeutics is a private company based in Boston, Massachusetts. It has reported $46,000,000 raised in one offering on Form D since November 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 18, 2024Nov 1, 2024$46,000,000of $115.0M target19$2.4MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Axonis Therapeutics's Form D filed Nov 1, 2024.

JI
Jeffrey Imbaro
Chief Operating Officer
CG
BR
Brock Reeve
Director
SH
Shane Hegarty
Executive officer
JS
Joanna Stanicka
Executive officer and director
JL

Sources

  1. SECAxonis Therapeutics, Inc. filing history